Skip to main content

Pakistan allows import, manufacture of Remdesivir for emergency COVID-19 use

The Drug Regulatory Authority of Pakistan has allowed the import and manufacturing of antiviral Remdesivir for severely ill COVID-19 patients, Radio Pakistan reported on Monday.

Registration letters were issued to two importers and 14 local manufacturers.

Remdesivir is an experimental antiviral drug that was invented as a potential treatment for Ebola. It has been approved for emergency use in Pakistan, according to the spokesperson of the Ministry of National Health Services.

DRAP’s registration board in its meeting held from June 8 to 11 had allowed the emergency use of Remdesivir.

The US Food and Drug Administration granted emergency use authorisation of the drug on May 1.

DRAP has only permitted health facilities treating COVID-19 patients to use the drug “in order to avoid the hoarding, profiteering and the distribution of Remdesivir through the black market, and its irrational use by healthcare professionals through private clinics.”

In an advisory for the use of Remdesivir, the regulatory body said unauthorised use by anyone other than designated public and private hospitals can be reported to the Quality Assurance and Lab Testing Division of DRAP and the provincial chief drug inspector.

Pharmaceutical companies and health facilities need to maintain a record of their Remdesivir inventory. Additionally, hospitals have to record patient information such as their biodata, disease severity and amount of Remdesivir administered to them.

The potential COVID-19 drug can only be used in children and adults if the following criteria are met: suspected or laboratory confirmed COVID-19, oxygen levels below 94% and requirement of supplemental oxygen, mechanical ventilation or extracorporeal membrane oxygenation.

Remdesivir should be given to hospitalised patients through an IV line by a healthcare provider under strict supervision of a qualified specialist, DRAP has instructed.

Serious side effects can be reported to the Pakistan National Pharmacovigilance Centre, through DRAP Med Vigilance e-reporting system: https://primaryreporting.whoumc.org/Reporting/Reporter?OrganizationID=PK, or via email to npc@dra.gov.pk.

DRAP has listed the following side effects: increased levels of liver enzymes due to inflammation in the liver and infusion-related reactions including low blood pressure, nausea, vomiting, sweating and shivering.



from SAMAA https://ift.tt/2Nh8FwW
Labels:

Comments

Post a Comment

Popular posts from this blog

Trump says he urged team to ‘slow’ COVID-19 testing

US President Donald Trump said Saturday he was encouraging health officials in his administration to slow down coronavirus testing, arguing that increased tests lead to more cases being discovered. The president has claimed falsely on several occasions that surges of COVID-19 in several states can be explained by greater numbers of diagnostic tests. At his first rally since the outbreak forced nationwide shutdowns in March, Trump told the crowd in Tulsa, Oklahoma that testing was a “double-edged sword.” The United States — which has more deaths and cases than any other country — has carried out more than 25 million coronavirus tests, placing it outside the top 20 countries in the world, per capita. “Here is the bad part: When you do testing to that extent, you are going to find more people, you will find more cases,” Trump argued. “So I said to my people ‘slow the testing down.’ They test and they test.” It was not clear from Trump’s tone if he was playing to the crowd, who ...
Post a Comment
Read more

IT ministry forms panel to review social media rules

ISLAMABAD: While uproar against the new rules to regulate social media continues from various segments of society, including parliamentarians, the Pakistan Federal Union of Journalists (PFUJ) and civil society, the information technology ministry on Friday formed a committee to review the rules. The federal cabinet approved the rules on Feb 11, but later after opposition from various quarters, including companies that manage different social media platforms, the prime minister announced that a fresh consultation process would be launched over the Citizens Protection (Against Online Harm) Rules 2020. The committee formed by the IT ministry is headed by Pakistan Telecommunication Authority Chairman Amir Azeem Bajwa while its members are Eazaz Aslam Dar, additional secretary of IT; Tania Aidrus, member of the Strategic Reforms Imple­mentation Unit, Prime Minister Office; and Dr Arslan Khalid, focal person on digital media at the PM Office. Federal Minister for Human Rights Dr Shireen Ma...
Post a Comment
Read more

IS confirms Baghdadi’s death, vows revenge

Abu Bakr al-Baghdadi.—AP BEIRUT: The Islamic State militant group confirmed the death of its leader Abu Bakr al-Baghdadi in a statement on Thursday and named his replacement as Abu Ibrahim al-Hashimi al-Quraishi. “We mourn you ... commander of the faithful,” said Abu Hamza al-Quraishi — presented as the group’s new spokesman — in an audio statement. Baghdadi, who led IS since 2014 and was the world’s most wanted man, was killed in a US special forces raid in Syria’s province of Idlib on Sunday. The group also confirmed the killing in another raid the following day of the group’s previous spokesman Abu Hassan al-Muhajir. The statement said the group’s legislative and consultative body convened after the 48-year-old Iraqi-born jihadist chief’s death. “The Islamic State shura council convened immediately after confirming the martyrdom of Sheikh Abu Bakr al-Baghdadi, and the elders of the holy warriors agreed” on a replacement, said the seven-minute message. Little is known abou...
Post a Comment
Read more